Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases
Saved in:
Main Authors: | Basveshwar Gawali, Shweta Shrivastava, R. Uday Kumar, Satyendra Kumar Rajput, Manish Kumar Jeengar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1559488/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01) -
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
by: Rosalie Matico, et al.
Published: (2024-12-01) -
RETRACTED ARTICLE: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
by: Jianbin Guan, et al.
Published: (2024-06-01) -
Phosphodiesterase Type 5 Inhibitors in Male Reproduction: Molecular Mechanisms and Clinical Implications for Fertility Management
by: Aris Kaltsas, et al.
Published: (2025-01-01) -
Editorial: Exploring novel approaches to small molecule kinase inhibitors in cancer treatment
by: Anna Carbone, et al.
Published: (2025-02-01)